alanylalanine and aspartyl-aspartic acid

alanylalanine has been researched along with aspartyl-aspartic acid in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brandsch, M; Gebauer, S; Hartrodt, B; Knütter, I; Neubert, K; Thondorf, I1
Scozzafava, A; Supuran, CT1
Biegel, A; Brandsch, M; Gebauer, S; Hartrodt, B; Neubert, K; Thondorf, I1
Faria, TN; Quan, Y; Smith, RL; Stouch, TR; Timoszyk, JK; Vig, BS; Wall, DA1
Aldini, G; De Luca, L; Marconi, C; Pedretti, A; Regazzoni, L; Vistoli, G1

Other Studies

5 other study(ies) available for alanylalanine and aspartyl-aspartic acid

ArticleYear
Three-dimensional quantitative structure-activity relationship analyses of peptide substrates of the mammalian H+/peptide cotransporter PEPT1.
    Journal of medicinal chemistry, 2003, Dec-18, Volume: 46, Issue:26

    Topics: Carrier Proteins; Dipeptides; Drug Design; Ligands; Models, Molecular; Molecular Conformation; Peptide Transporter 1; Protein Binding; Quantitative Structure-Activity Relationship; Symporters

2003
Carbonic anhydrase activators: human isozyme II is strongly activated by oligopeptides incorporating the carboxyterminal sequence of the bicarbonate anion exchanger AE1.
    Bioorganic & medicinal chemistry letters, 2002, Apr-22, Volume: 12, Issue:8

    Topics: Anion Exchange Protein 1, Erythrocyte; Binding Sites; Carbonic Anhydrases; Enzyme Activation; Enzyme Activators; Humans; Isoenzymes; Models, Molecular; Oligopeptides

2002
Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
    Journal of medicinal chemistry, 2005, Jun-30, Volume: 48, Issue:13

    Topics: Animals; beta-Lactams; Cell Line, Tumor; Dipeptides; Drug Design; Humans; Mammals; Models, Molecular; Oligopeptides; Peptide Transporter 1; Quantitative Structure-Activity Relationship; Substrate Specificity; Symporters

2005
Human PEPT1 pharmacophore distinguishes between dipeptide transport and binding.
    Journal of medicinal chemistry, 2006, Jun-15, Volume: 49, Issue:12

    Topics: Animals; Binding Sites; Biological Transport; Cell Line; Dipeptides; Dogs; Electricity; Hydrophobic and Hydrophilic Interactions; Models, Molecular; Peptide Transporter 1; Proline; Protein Binding; Protein Conformation; Structure-Activity Relationship; Symporters

2006
Fragmental modeling of hPepT2 and analysis of its binding features by docking studies and pharmacophore mapping.
    Bioorganic & medicinal chemistry, 2011, Aug-01, Volume: 19, Issue:15

    Topics: Binding Sites; Computer Simulation; Drug Design; Humans; Ligands; Models, Molecular; Peptides; Protein Binding; Structural Homology, Protein; Symporters

2011